Breaking news – Pagina 134 – AMD

Breaking news

Dicembre 9, 2022 Alice Lione

Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort study

Cheung JTK, Yang A, Wu H, et al.
Diabetes Res Clin Pract. Pub. online 6 Dec 2022.

Leggi

Dicembre 9, 2022 Alice Lione

Two decades of diabetes prevention efforts: a call to innovate and revitalize our approach to lifestyle change

Golovaty I, Ritchie ND, Tuomilehto J, et al.
Diabetes Res Clin Pract. 2022;110195.

Leggi

Dicembre 6, 2022 Alice Lione

LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

Urva S, Coskun T, Loh MT, et al.
Lancet. 2022;400(10366):1869-1881.

Leggi

Dicembre 9, 2022 Alice Lione

Comparison of sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist prescribing in patients with diabetes mellitus with and without cardiovascular disease

Gay HC, Yu J, Persell SD, et al.
Am J Cardiol. 2022;S0002-9149(22)01131-6.

Leggi

Dicembre 6, 2022 Alice Lione

Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering

Mistry S, Gouripeddi R, Raman V, Facelli JC
Diabetologia. 2022 Nov 30.

Leggi

Dicembre 6, 2022 Alice Lione

Fully closed-loop insulin delivery in patients undergoing pancreatic surgery

Krutkyte G, Roos J, Schuerch D, et al.
Diabetes Technol Ther. 2022 Nov 30.

Leggi

Dicembre 5, 2022 Alice Lione

KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
Kidney Int. 2022;102(5S):S1-S127.

Leggi

Dicembre 6, 2022 Alice Lione

Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease – analyses from VERTIS CV, a randomized trial of the SGLT2 inhibitor ertugliflozin

Corbin KD, Dagogo-Jack S, Cannon CP, et al.
Diabetes Obes Metab. 2022 Nov 17.

Leggi

Dicembre 6, 2022 Alice Lione

The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes

Ferrannini E, Mari A, Monaco GSF, et al.
Diabetologia. 2022 Dec 2.

Leggi

Novembre 30, 2022 Alice Lione

A randomized crossover pilot study evaluating glucose control during exercise initiated 1 or 2h after a meal in adults with type 1 diabetes treated with an automated insulin delivery system.

Myette-Cote E, Molveau J, Wu Z, et al.
Diabetes Technol Ther. Pub. online 18 Nov 2022.

Leggi